BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17644434)

  • 1. Albumin-quercetin combination offers a therapeutic advantage in the prevention of reduced survival of erythrocytes in visceral leishmaniasis.
    Sen G; Biswas D; Ray M; Biswas T
    Blood Cells Mol Dis; 2007; 39(3):245-54. PubMed ID: 17644434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis.
    Sen G; Mandal S; Saha Roy S; Mukhopadhyay S; Biswas T
    Free Radic Biol Med; 2005 May; 38(9):1257-64. PubMed ID: 15808423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity.
    Sen G; Mukhopadhyay S; Ray M; Biswas T
    J Antimicrob Chemother; 2008 May; 61(5):1066-75. PubMed ID: 18285311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of ascorbate and alpha-tocopherol as a preventive therapy against structural and functional defects of erythrocytes in visceral leishmaniasis.
    Sen G; Mukhopadhaya R; Ghosal J; Biswas T
    Free Radic Res; 2004 May; 38(5):527-34. PubMed ID: 15293561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory role of nitric oxide in the reduced survival of erythrocytes in visceral leishmaniasis.
    Chowdhury KD; Sen G; Biswas T
    Biochim Biophys Acta; 2010 Sep; 1800(9):964-76. PubMed ID: 20576500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid peroxidation of erythrocytes during anemia of the hamsters infected with Leishmania donovani.
    Biswas T; Pal JK; Naskar K; Ghosh DK; Ghosal J
    Mol Cell Biochem; 1995 May; 146(2):99-105. PubMed ID: 7565650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell survival and iron kinetics in kala-azar.
    Musumeci S; Romeo M; D'Agata A
    J Trop Med Hyg; 1974 May; 77(5):106-10. PubMed ID: 4835324
    [No Abstract]   [Full Text] [Related]  

  • 8. Anemia in experimental visceral leishmaniasis in hamsters.
    Biswas T; Chakraborty M; Naskar K; Ghosh DK; Ghosal J
    J Parasitol; 1992 Feb; 78(1):140-2. PubMed ID: 1310731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased lipid fluidity of the erythrocyte membrane in dogs with leishmaniasis-associated anaemia.
    De Luna R; Ferrante M; Severino L; Ambrosio R; Piantedosi D; Gradoni L; Lucisano A; Persechino A
    J Comp Pathol; 2000; 122(2-3):213-6. PubMed ID: 10684691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of ascorbate and alpha-tocopherol enhances antioxidant reserve of erythrocytes during anemia in visceral leishmaniasis.
    Sen G; Mukhopadhaya R; Ghosal J; Biswas T
    Life Sci; 2000 Nov; 67(26):3181-90. PubMed ID: 11191625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of sulfhydryl groups in band 3 in the inhibition of phosphate transport across erythrocyte membrane in visceral leishmaniasis.
    Roy SS; Sen G; Biswas T
    Arch Biochem Biophys; 2005 Apr; 436(1):121-7. PubMed ID: 15752716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for visceral leishmaniasis.
    den Boer M; Davidson RN
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):187-97. PubMed ID: 16597201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case for the panel. Visceral leishmaniasis: I. Unusual interrelationships between immature erythrocytes and both parasites and mature erythrocytes.
    el-Shoura SM
    Ultrastruct Pathol; 1992; 16(5):593-9. PubMed ID: 1332239
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo efficacy of calceolarioside A against experimental visceral leishmaniasis.
    Poddar A; Banerjee A; Ghanta S; Chattopadhyay S
    Planta Med; 2008 Apr; 74(5):503-8. PubMed ID: 18543147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of hemoglobin and redistribution of band 3 promote erythrophagocytosis in visceral leishmaniasis.
    Saha Roy S; Chowdhury KD; Sen G; Biswas T
    Mol Cell Biochem; 2009 Jan; 321(1-2):53-63. PubMed ID: 18777164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative damage of erythrocytes: a possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters.
    Sen G; Mukhopadhyay R; Ghosal J; Biswas T
    Ann Hematol; 2001 Jan; 80(1):32-7. PubMed ID: 11233773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol: a potential therapeutic target in Leishmania infection?
    Pucadyil TJ; Chattopadhyay A
    Trends Parasitol; 2007 Feb; 23(2):49-53. PubMed ID: 17185038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vegetable flavonoids and cardiovascular disease.
    Terao J; Kawai Y; Murota K
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():291-3. PubMed ID: 18296359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of fatal visceral leishmaniasis at an Indian tertiary care center.
    Malatesha G; Mathur P; Madan K; Samanta P; Samantaray JC
    Trop Gastroenterol; 2007; 28(1):28-31. PubMed ID: 17896607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
    Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
    J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.